85.97
Spdr Biotech Etf Aktie (XBI) Neueste Nachrichten
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by US Bancorp DE - Defense World
Form 424B2 MORGAN STANLEY - StreetInsider.com
(XBI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Guarantor: JPMorgan Chase & Co. - StreetInsider.com
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Jefferies Predicts Up to ~500% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Top-rated biotechs with negative enterprise values - MSN
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
Van ECK Associates Corp Makes New $1.50 Million Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Vontobel Holding Ltd. Has $621,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Allspring Global Investments Holdings LLC Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Mirae Asset Global Investments Co. Ltd. Has $299,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
How to Take Advantage of moves in (XBI) - Stock Traders Daily
Unlocking the Mystery of Smart Beta: A Deep Dive into the iShares Biotechnology ETF - Clinique Bio
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - TradingView
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - MSN
Can Health Care ETFs Aid Your Portfolio? - ETF Trends
Should You Invest in the iShares Biotechnology ETF (IBB)? - Nasdaq
(XBI) On The My Stocks Page - Stock Traders Daily
Want To Make Money In Biotech Stocks? Check Out OSE Immunotherapeutics - Forbes
7 Best-Performing Biotech ETFs for February 2025 - NerdWallet
XBI: Diverse Holding Amid Strong Catalysts, Buy - Seeking Alpha
Janney Montgomery Scott LLC Has $7.51 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (XBI): How to Buy - The Motley Fool
(XBI) Trading Advice - Stock Traders Daily
3 Biotech Stocks With Notable Insider Buying - Seeking Alpha
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - TradingView
Wealthcare Advisory Partners LLC Sells 299 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Brookstone Capital Management Trims Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
August 15th Options Now Available For SPDR Series TrustS&P Biotech ETF (XBI) - Nasdaq
'Buy Long Duration Bonds,' Says Bank Of America Strategist: 4 ETFs To Watch As Trump's Deficit Fight Unfolds - Benzinga
GAMMA Investing LLC Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care ETFs to Buy for 2025 | Investing - U.S News & World Report Money
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Objective long/short (XBI) Report - Stock Traders Daily
XHE: 3 Healthcare ETFs for Defensive Investing - StockNews.com
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
Record Growth: This Year’s Biotech Stocks Shock the Market! Don’t Miss Out! - Clinique Bio
(XBI) Technical Data - Stock Traders Daily
StockWatch: Wall Street’s Leaders and Laggards of 2024 - Genetic Engineering & Biotechnology News
SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Fmr LLC Has $686,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Sees Unusually High Options Volume (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech (XBI) Shares Cross Below 200 DMA - Nasdaq
Page 24 | SPDR S&P BIOTECH ETF Trade Ideas — HAN:SSGF - TradingView
Technical Indicators Signal Mixed Trends for Biotechnology Sector - Head Topics
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):